SNAPSHOT OF THE PHARMACEUTICAL SECTOR

Overview

     The pharmaceutical industry is one of Uzbekistan's fastest-growing manufacturing sectors, driven by rising healthcare demand, rapid population growth, import substitution policies, and sustained government support for localization and foreign investment. According to the results of 2025, the sector continued to expand production capacity, strengthen domestic manufacturing, and improve access to modern pharmaceutical products, contributing to the country's healthcare security and industrial development.

Industry Development

     Uzbekistan's pharmaceutical industry encompasses the production and distribution of medicines, medical devices, biotechnology products, and other healthcare solutions. According to the results of 2025, pharmaceutical production reached approximately USD 490 million, while exports of pharmaceutical products and services totaled around USD 250 million. The sector also attracted planned investments worth USD 453 million, reflecting growing confidence among both domestic and international investors.

Special Economic Zones and Investment Support

     To accelerate industry development, Uzbekistan has established six specialized Pharmaceutical Special Economic Zones (SEZs): Syrdarya-Pharm, Parkent-Pharm, Bustonlik-Pharm, Andijan Pharm, Kosonsoy-Pharm, and Zomin-Pharm. These zones provide a favorable investment environment through a range of incentives, including customs duty and VAT exemptions, preferential access to government procurement, and reimbursement mechanisms for international pharmaceutical registration expenses, supporting the localization of high-value pharmaceutical production.

Regulatory Reforms and Investment Opportunities

     The government continues implementing comprehensive reforms aimed at improving pharmaceutical regulation, simplifying licensing procedures, and accelerating the registration of medicines through international mutual recognition mechanisms. These measures reduce time-to-market for innovative pharmaceutical products and improve market accessibility for investors. According to the results of 2025, 32 new pharmaceutical projects were planned across medicine manufacturing, biotechnology, medical equipment production, and pharmaceutical logistics, creating significant opportunities for investment throughout the industry's value chain.

Future Outlook

   Supported by strong demographic growth, rising healthcare expenditure, expanding private healthcare services, and a favorable investment climate, Uzbekistan's pharmaceutical sector offers substantial long-term growth potential. Continued government support for localization, innovation, and international partnerships is expected to further strengthen the country's position as one of the leading pharmaceutical investment destinations in Central Asia and the CIS region.